134 related articles for article (PubMed ID: 23291911)
21. Stable amino-acid sequence of the mannose-6-phosphate/insulin-like growth-factor-II receptor in ovarian carcinomas with loss of heterozygosity and in breast-cancer cell lines.
Rey JM; Theillet C; Brouillet JP; Rochefort H
Int J Cancer; 2000 Feb; 85(4):466-73. PubMed ID: 10699916
[TBL] [Abstract][Full Text] [Related]
22. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
23. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
[TBL] [Abstract][Full Text] [Related]
24. Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
Press JZ; De Luca A; Boyd N; Young S; Troussard A; Ridge Y; Kaurah P; Kalloger SE; Blood KA; Smith M; Spellman PT; Wang Y; Miller DM; Horsman D; Faham M; Gilks CB; Gray J; Huntsman DG
BMC Cancer; 2008 Jan; 8():17. PubMed ID: 18208621
[TBL] [Abstract][Full Text] [Related]
25. NR5A1 mutations are not associated with male infertility in Indian men.
Sudhakar DVS; Nizamuddin S; Manisha G; Devi JR; Gupta NJ; Chakravarthy BN; Deenadayal M; Singh L; Thangaraj K
Andrologia; 2018 Apr; 50(3):. PubMed ID: 29265478
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive sequence analysis of the NR5A1 gene encoding steroidogenic factor 1 in a large group of infertile males.
Röpke A; Tewes AC; Gromoll J; Kliesch S; Wieacker P; Tüttelmann F
Eur J Hum Genet; 2013 Sep; 21(9):1012-5. PubMed ID: 23299922
[TBL] [Abstract][Full Text] [Related]
28. Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer.
Felts SJ; Van Keulen VP; Hansen MJ; Bell MP; Allen K; Belachew AA; Vile RG; Cunningham JM; Hoskin TL; Pankratz VS; Pease LR
Neoplasia; 2015 Apr; 17(4):348-57. PubMed ID: 25925377
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors.
Menendez L; Walker LD; Matyunina LV; Totten KA; Benigno BB; McDonald JF
Mol Cancer; 2008 May; 7():43. PubMed ID: 18498645
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
[TBL] [Abstract][Full Text] [Related]
31. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
32. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
33. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
34. Loss of OPCML expression and the correlation with CpG island methylation and LOH in ovarian serous carcinoma.
Chen H; Ye F; Zhang J; Lu W; Cheng Q; Xie X
Eur J Gynaecol Oncol; 2007; 28(6):464-7. PubMed ID: 18179137
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity: what is it good for?
Ryland GL; Doyle MA; Goode D; Boyle SE; Choong DY; Rowley SM; Li J; ; Bowtell DD; Tothill RW; Campbell IG; Gorringe KL
BMC Med Genomics; 2015 Aug; 8():45. PubMed ID: 26231170
[TBL] [Abstract][Full Text] [Related]
36. PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas.
Ho CM; Lin MC; Huang SH; Huang CJ; Lai HC; Chien TY; Chang SF
Gynecol Oncol; 2009 Feb; 112(2):307-13. PubMed ID: 19007975
[TBL] [Abstract][Full Text] [Related]
37. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
38. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
40. SF1 and spleen development: new heterozygous mutation, literature review and consequences for NR5A1-mutated patient's management.
Colson C; Aubry E; Cartigny M; Rémy AA; Franquet H; Leroy X; Kéchid G; Lefèvre C; Besson R; Cools M; Spinoit AF; Sultan C; Manouvrier S; Philibert P; Ghoumid J
Clin Genet; 2017 Jul; 92(1):99-103. PubMed ID: 28032338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
